VP, Medical Affairs

Legend Biotech is a global biotechnology company dedicated to treating and, one day, curing life-threatening diseases. Headquartered in Bridgewater, New Jersey, we are advancing the next generation of cell therapy through a portfolio of innovative technologies, including autologous, allogeneic, and in vivo cell therapy approaches. Our research spans chimeric antigen receptor T-cell (CAR-T), T-cell receptor (TCR-T), natural killer (NK) cell-based therapies, and other emerging platforms designed to transform the treatment of serious diseases. From our global network of research and development sites, we are committed to discovering and developing safe, effective, and cutting-edge therapies for patients worldwide.

Legend Biotech entered into a global collaboration agreement with Johnson & Johnson to jointly develop and commercialize CARVYKTI® (ciltacabtagene autoleucel; cilta-cel). Through this strategic partnership, we combine complementary expertise and capabilities to advance innovative immunotherapies for patients living with multiple myeloma.

Legend Biotech is seeking a VP of Medical Affairs as part of the Medical Affairs team based in Bridgewater, NJ.

The VP of Medical Affairs is an essential role in the company with significant impact on the clinical understanding of Legend’s approved BCMA CAR-T for multiple myeloma, as well the development of pipeline programs. The VP of Medical Affairs will provide strategic leadership to develop and execute an integrated Medical Affairs Strategy, working closely with collaboration partners, such as Johnson & Johnson, as well as partners within the company such as Commercial, Clinical Development, Translational Development, Safety, Regulatory, Healthcare Compliance and Legal. Core responsibilities will encompass developing & executing medical affairs strategy and providing leadership and direction to the medical affairs team (home office and field-based) and executing on significant initiatives including scientific communications, publications, lifecycle planning, data generation, KOL engagement, and educational programming. In addition, this leader will help build Medical Affairs capabilities to support our emerging pipeline.

This position reports to the President of the CARVYKTI business unit and is a member of the CARVYKTI leadership team, with close collaboration with the President of R&D.

• Positively impact the educational and clinical needs of the multiple myeloma-treating community (and more broadly the hematology community) in understanding the role of BCMA CAR-T in the treatment landscape, including its use earlier in the treatment paradigm.

• Oversee a team of 16+ MSL’s plus MSL management, and ensure they have high impact in the activities and programs they conduct.

• <span style="font-family: arial,